Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2023 28
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics of incidental prostate cancer in the United States.
Scheipner L, Incesu RB, Morra S, Baudo A, Assad A, Jannello LMI, Siech C, de Angelis M, Barletta F, Tian Z, Saad F, Shariat SF, Briganti A, Chun FKH, Tilki D, Longo N, Carmignani L, De Cobelli O, Ahyai S, Karakiewicz PI. Scheipner L, et al. Prostate Cancer Prostatic Dis. 2023 Oct 23. doi: 10.1038/s41391-023-00742-7. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37872250
Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era.
Scheipner L, Barletta F, Cano Garcia C, Incesu RB, Morra S, Baudo A, Assad A, Tian Z, Saad F, Shariat SF, Briganti A, Chun FKH, Tilki D, Longo N, Carmignani L, Pichler M, Ahyai S, Karakiewicz PI. Scheipner L, et al. Ann Surg Oncol. 2023 Dec;30(13):8780-8785. doi: 10.1245/s10434-023-14367-6. Epub 2023 Oct 10. Ann Surg Oncol. 2023. PMID: 37815682 Free PMC article.
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites.
Tappero S, Piccinelli ML, Incesu RB, Cano Garcia C, Barletta F, Morra S, Scheipner L, Baudo A, Tian Z, Parodi S, Dell'Oglio P, de Cobelli O, Graefen M, Chun FKH, Briganti A, Longo N, Ahyai S, Carmignani L, Saad F, Shariat SF, Suardi N, Borghesi M, Terrone C, Karakiewicz PI. Tappero S, et al. Among authors: scheipner l. Clin Genitourin Cancer. 2024 Apr;22(2):47-55.e2. doi: 10.1016/j.clgc.2023.08.004. Epub 2023 Aug 11. Clin Genitourin Cancer. 2024. PMID: 37690970
Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites.
Tappero S, Barletta F, Piccinelli ML, Cano Garcia C, Incesu RB, Morra S, Scheipner L, Baudo A, Tian Z, Parodi S, Dell'Oglio P, Briganti A, de Cobelli O, Chun FKH, Graefen M, Longo N, Ahyai S, Carmignani L, Saad F, Shariat SF, Suardi N, Borghesi M, Terrone C, Karakiewicz PI. Tappero S, et al. Among authors: scheipner l. Urol Oncol. 2024 Jan;42(1):22.e23-22.e31. doi: 10.1016/j.urolonc.2023.08.014. Epub 2023 Sep 28. Urol Oncol. 2024. PMID: 37775340
Conditional survival of stage III non-seminoma testis cancer patients.
Incesu RB, Barletta F, Tappero S, Morra S, Garcia CC, Scheipner L, Piccinelli ML, Tian Z, Saad F, Shariat SF, de Cobelli O, Ahyai S, Chun FKH, Longo N, Terrone C, Briganti A, Tilki D, Graefen M, Karakiewicz PI. Incesu RB, et al. Among authors: scheipner l. Urol Oncol. 2023 Oct;41(10):435.e11-435.e18. doi: 10.1016/j.urolonc.2023.06.005. Epub 2023 Aug 7. Urol Oncol. 2023. PMID: 37558516
Identifying low cancer-specific mortality risk lymph node-positive radical prostatectomy patients.
Barletta F, Tappero S, Morra S, Incesu RB, Cano Garcia C, Piccinelli ML, Scheipner L, Tian Z, Gandaglia G, Stabile A, Mazzone E, Terrone C, Longo N, Tilki D, Chun FKH, de Cobelli O, Ahyai S, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Barletta F, et al. Among authors: scheipner l. J Surg Oncol. 2024 Mar 12. doi: 10.1002/jso.27612. Online ahead of print. J Surg Oncol. 2024. PMID: 38470523
Survival differences in non-seminoma testis cancer patients according to race/ethnicity.
Incesu RB, Barletta F, Tappero S, Piccinelli ML, Garcia CC, Morra S, Scheipner L, Tian Z, Saad F, Shariat SF, Ahyai S, Longo N, Chun FKH, de Cobelli O, Terrone C, Briganti A, Tilki D, Graefen M, Karakiewicz PI. Incesu RB, et al. Among authors: scheipner l. Cancer Epidemiol. 2024 Apr;89:102538. doi: 10.1016/j.canep.2024.102538. Epub 2024 Feb 20. Cancer Epidemiol. 2024. PMID: 38377946
In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery.
Cano Garcia C, Tappero S, Piccinelli ML, Barletta F, Incesu RB, Morra S, Scheipner L, Baudo A, Tian Z, Hoeh B, Chierigo F, Sorce G, Saad F, Shariat SF, Carmignani L, Ahyai S, Longo N, Tilki D, Briganti A, De Cobell O, Dell'Oglio P, Mandel P, Terrone C, Chun FKH, Karakiewicz PI. Cano Garcia C, et al. Among authors: scheipner l. Ann Surg Oncol. 2023 Dec;30(13):8770-8779. doi: 10.1245/s10434-023-14246-0. Epub 2023 Sep 18. Ann Surg Oncol. 2023. PMID: 37721691 Free PMC article.
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer.
Scheipner L, Zurl H, Altziebler JV, Pichler GP, Schöpfer-Schwab S, Jasarevic S, Gaisl M, Pohl KC, Pemberger K, Andlar S, Hutterer GC, Bele U, Leitsmann C, Leitsmann M, Augustin H, Zigeuner R, Ahyai S, Mischinger J. Scheipner L, et al. Cancers (Basel). 2023 Dec 8;15(24):5770. doi: 10.3390/cancers15245770. Cancers (Basel). 2023. PMID: 38136315 Free PMC article.
46 results